About Max
This author has not written his bio yet.
But we are proud to say that Max contributed 314 entries already.
Entries by Max
Newsletter 7
/0 Comments/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week HAPPY NEW YEAR! Before we dive into the latest news from prostatewarriors.com I want to wish you all a great 2025! The seventh and final newsletter of 2024 is here, bringing you fresh insights and renewed hope. We also have a podcast if you prefer […]
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
abiraterone acetate ADC ADT AI ai in healthcare antibody-drug conjugate apalutamide artificial intelligence ASCO 2025 ATM bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy castration-resistant prostate cancer clinical trial clinical trials crispr CYP11A1 inhibitor darolutamide drug repurposing drug resistance enzalutamide HRR HRRm immune checkpoint inhibitors immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA nanotechnology olaparib oncolytic virus personalized medicine prostate cancer PSMA radioligand therapy radiopharmaceuticals real-world data T-cell therapy theranostics
Latest Posts
- Newsletter 24/2025 June 15, 2025
- Cholesterol Identified as Key Shield in Heat-Resistant Cancer Cells June 13, 2025
- ATRN-119: A New Promising ATR Inhibitor for ATM Mutations (And Other HRR Mutations) June 13, 2025
- UPDATE: OncoACP3 Moving to Phase 1 Trial as Therapeutic Agent June 12, 2025